Cochrane Nursing Care Field

Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer

Karolina Lisy

receptor, colorectal cancer, literature review, intervention
CJON 2013, 17(2), 211-212. DOI: 10.1188/13.CJON.211-212

Objective: To assess whether histamine type 2 receptor antagonists (H2RAs) improve overall survival when used as pre-, peri-, or postoperative therapy in patients with colorectal cancer who had surgical resection with curative intent.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.